HSBC Holdings’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-72,030
Closed -$1.26M 2917
2025
Q3
$1.26M Sell
72,030
-20,367
-22% -$302K ﹤0.01% 1706
2025
Q2
$1.28M Buy
92,397
+36,591
+66% +$589K ﹤0.01% 1682
2025
Q1
$1.03M Buy
55,806
+40,063
+254% +$597K ﹤0.01% 1743
2024
Q4
$175K Sell
15,743
-354
-2% -$4.14K ﹤0.01% 2758
2024
Q3
$188K Buy
16,097
+4,726
+42% +$44.7K ﹤0.01% 2637
2024
Q2
$86.2K Sell
11,371
-21,097
-65% -$138K ﹤0.01% 2759
2024
Q1
$161K Buy
32,468
+17,385
+115% +$111K ﹤0.01% 2743
2023
Q4
$134K Sell
15,083
-14,375
-49% -$105K ﹤0.01% 2546
2023
Q3
$206K Buy
+29,458
New +$178K ﹤0.01% 2410

Other funds holding ALHC

HSBC Holdings's ALHC Position: Q4 2025 in Review

HSBC Holdings sold out of Alignment Healthcare (ALHC) in Q4 2025, closing a stake of 72,030 shares — an estimated $1.26M sold.

HSBC Holdings first reported a position in ALHC in Q3 2023 and held it in 9 quarters. The position peaked at $1.28M in Q2 2025. 263 funds tracked by Wall St. Rank hold ALHC as of Q4 2025.

  • HSBC Holdings reported no remaining Alignment Healthcare position as of Q4 2025 after selling out during the quarter.
  • HSBC Holdings sold 72,030 Alignment Healthcare shares in Q4 2025, an estimated $1.26M.
  • HSBC Holdings first reported a position in Alignment Healthcare in Q3 2023 and held it in 9 quarters.
  • HSBC Holdings's Alignment Healthcare position peaked at $1.28M in Q2 2025.
  • 263 funds tracked by Wall St. Rank held Alignment Healthcare as of Q4 2025.

Based on HSBC Holdings's 13F filing for Q4 2025, filed 6 Mar 2026.